Page last updated: 2024-09-03

cp 122288 and naratriptan

cp 122288 has been researched along with naratriptan in 1 studies

Compound Research Comparison

Studies (cp 122288)	Trials (cp 122288)	Recent Studies (post-2010) (cp 122288)	Studies (naratriptan)	Trials (naratriptan)	Recent Studies (post-2010) (naratriptan)
17	1	0	205	24	48

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beleta, J; Doménech, T; Palacios, JM	1

Other Studies

1 other study(ies) available for cp 122288 and naratriptan

Article	Year
Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist. Naunyn-Schmiedeberg's archives of pharmacology, 1997, Volume: 356, Issue:3 Topics: Benzamides; Binding, Competitive; Gene Expression; HeLa Cells; Humans; Kinetics; Ligands; Pyridines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Substantia Nigra; Tritium	1997

Article

Year

Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist.

Naunyn-Schmiedeberg's archives of pharmacology, 1997, Volume: 356, Issue:3

Topics: Benzamides; Binding, Competitive; Gene Expression; HeLa Cells; Humans; Kinetics; Ligands; Pyridines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Substantia Nigra; Tritium

1997